1. Home
  2. STN vs BMRN Comparison

STN vs BMRN Comparison

Compare STN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stantec Inc

STN

Stantec Inc

HOLD

Current Price

$71.68

Market Cap

10.3B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$55.99

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STN
BMRN
Founded
1954
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
10.4B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
STN
BMRN
Price
$71.68
$55.99
Analyst Decision
Buy
Buy
Analyst Count
1
18
Target Price
$175.00
$88.22
AVG Volume (30 Days)
344.8K
2.3M
Earning Date
05-13-2026
05-04-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$11.06
$15.02
Revenue Next Year
$6.61
$12.23
P/E Ratio
$28.96
$104.02
Revenue Growth
N/A
17.62
52 Week Low
$71.33
$49.26
52 Week High
$114.52
$66.28

Technical Indicators

Market Signals
Indicator
STN
BMRN
Relative Strength Index (RSI) 31.01 54.80
Support Level N/A $51.74
Resistance Level $96.29 $56.91
Average True Range (ATR) 2.17 1.81
MACD 0.08 0.47
Stochastic Oscillator 1.46 65.89

Price Performance

Historical Comparison
STN
BMRN

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: